Insight

Varadha Balaji Venkadakrishnan: Lineage-specific activity of EZH2 in advanced Prostate Cancer

Photo from Varadha Balaji Venkadakrishnan/X

Aug 12, 2024, 22:05

Varadha Balaji Venkadakrishnan: Lineage-specific activity of EZH2 in advanced Prostate Cancer

Varadha Balaji Venkadakrishnan, Postdoctoral Researcher at Dana-Farber Cancer Institute, shared on X about a recent paper titled “Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes” published in Nature Communications.

Authors: Varadha Balaji Venkadakrishnan et al.

specific activity

“Check out our paper on lineage-specific activity of EZH2 in advanced Prostate Cancer subtypes published in Nature Communications.

Thank you Misha Beltran for strong support!”

specific activity

Source: Varadha Balaji Venkadakrishnan/X

Adam Presser cancer Dana-Farber Cancer Institute David Rickman EZH2 Himisha Beltran Misha Beltran Myles Brown National Cancer Center Nature Communications OncoDaily Oncology PCF Science prostate cancer Richa Singh Varadha Balaji Venkadakrishnan

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage